Literature DB >> 11710016

Polysaccharide--polynucleotide complexes. 2. Complementary polynucleotide mimic behavior of the natural polysaccharide schizophyllan in the macromolecular complex with single-stranded RNA and DNA.

K Sakurai1, M Mizu, S Shinkai.   

Abstract

Schizophyllan is an extracellular polysaccharide consisting of a beta-1,3-D-glucan main chain and exists as a triple helix in water and as a single chain in dimethyl sulfoxide (DMSO). When the single chain of schizophyllan (s-SPG) was mixed with poly(C), poly(A), poly(dA), or poly(dT), they form a macromolecular complex. On the other hand, poly(G), poly(U), poly(I), poly(dG), and poly(dC) do not. This nucleotide specificity evidences that the hydrogen bonds are essential to form the complex, because the former nucleotides have an unoccupied hydrogen-bonding site and the latter ones use the hydrogen-bonding sites in the intramolecular aggregation (i.e., such as the G quartet for poly(G) and poly(dG) and the U hairpin for poly(U)). The hypochromic effect and the increment in the circular dichroism (CD) intensity are observed in accordance with the complex formation. These facts indicate that the base stacking is enhanced in the complex. The solvent-composition (DMSO/water) dependence demonstrates that the hydrophobic interaction is important to form the complex as well as the hydrogen-bonding interaction. With increasing temperature the complex dissociates cooperatively and the melting curve enables the thermodynamic parameters to be evaluated (delta H = -60 to 70 kcal mol-1 and delta S = -150 to 200 cal mol-1 K-1). These values are comparable with those for double helix DNA. Namely, the complex can be characterized by enhancement of the base stacking, cooperative dissociation, the similar thermodynamic parameters to DNA, and combination of the hydrogen-bonding and hydrophobic interactions to form the higher-order structure. These facts surprisingly coincide with characters of the double helix of DNA. In other words, the s-SPG molecule behaves as if it were a complementary polynucleotide chain for the corresponding polynucleotide. Furthermore, stoichiometric study suggested that the complex structure is a triple helix consisting of two s-SPG and one poly(C) or poly(A) chains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710016     DOI: 10.1021/bm000121r

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  8 in total

1.  A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease.

Authors:  Hidetoshi Takedatsu; Keiichi Mitsuyama; Shinichi Mochizuki; Teppei Kobayashi; Kazuo Sakurai; Hiroshi Takeda; Yoshihide Fujiyama; Yoshikazu Koyama; Jun Nishihira; Michio Sata
Journal:  Mol Ther       Date:  2012-02-14       Impact factor: 11.454

Review 2.  Carbohydrate polymers for nonviral nucleic acid delivery.

Authors:  Antons Sizovs; Patrick M McLendon; Sathya Srinivasachari; Theresa M Reineke
Journal:  Top Curr Chem       Date:  2010

3.  Preparation of poly(vinyl alcohol)/DNA hydrogels via hydrogen bonds formed on ultra-high pressurization and controlled release of DNA from the hydrogels for gene delivery.

Authors:  Tsuyoshi Kimura; Sayaka Iwai; Toshiyuki Moritan; Kwangwoo Nam; Shingo Mutsuo; Hidekazu Yoshizawa; Masahiro Okada; Tsutomu Furuzono; Tosihya Fujisato; Akio Kishida
Journal:  J Artif Organs       Date:  2007-06-20       Impact factor: 1.731

4.  Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist.

Authors:  Kouji Kobiyama; Taiki Aoshi; Hirotaka Narita; Etsushi Kuroda; Masayuki Hayashi; Kohhei Tetsutani; Shohei Koyama; Shinichi Mochizuki; Kazuo Sakurai; Yuko Katakai; Yasuhiro Yasutomi; Shinobu Saijo; Yoichiro Iwakura; Shizuo Akira; Cevayir Coban; Ken J Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

Review 5.  Molecular function of macrophage migration inhibitory factor and a novel therapy for inflammatory bowel disease.

Authors:  Jun Nishihira
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

Review 6.  CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies.

Authors:  Nobutaka Hanagata
Journal:  Int J Nanomedicine       Date:  2017-01-16

Review 7.  Carbohydrate Conjugates in Vaccine Developments.

Authors:  Shuyao Lang; Xuefei Huang
Journal:  Front Chem       Date:  2020-04-15       Impact factor: 5.221

8.  Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel β-Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation.

Authors:  Hideto Sakisaka; Hidetoshi Takedatsu; Keiichi Mitsuyama; Shinichi Mochizuki; Kazuo Sakurai; Shotaro Sakisaka; Fumihito Hirai
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.